Akira Kanda

3.2k citations
100 papers · 2.4k indexed · h-index 23

Impact in

Papers in

Akira Kanda

92 papers receiving 2.3k citations

Peers

Akira Kanda
Comparison fields: 5 of 119
  • Immunology and Allergy 444
  • Physiology 845
  • Otorhinolaryngology 135
  • Emergency Medical Services 190
  • Immunology 550
Replace A Riccio with:
A Riccio Italy
Mara De Amici Italy
Daniel P. Potaczek Germany
Shuichiro Maruoka Japan
Pankaj Bhavsar United Kingdom
Sergejs Berdnikovs United States
Oliviero Sacco Italy
John B. Trudeau United States
Shigeharu Myou Japan
Paulina Wawrzyniak Switzerland
Akira Kanda relative to A Riccio Italy A Riccio's profile →
Citations per field
00.5×1.6×
A Riccio · 1×
Citations per year

Countries citing papers authored by Akira Kanda

Since Specialization
Citations

This map shows the geographic impact of Akira Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Kanda more than expected).

Fields of papers citing papers by Akira Kanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Kanda. The network helps show where Akira Kanda may publish in the future.

Co-authors

The 25 scholars most cited alongside Akira Kanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Akira Kanda Line = papers co-authored together Akira Kanda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20243
3 20231
4 20224
5 202214
6 202211
7 202115
8 20218
9 20212
10 202016
11 20191
12 201928
13 20194
14 20140
15 201122
16 2010151
17 200919
18 200553
19 19972
20 19841

About Akira Kanda

Akira Kanda is a scholar working on Immunology and Allergy, Otorhinolaryngology, Physiology, Sensory Systems and Immunology, having authored 100 papers that have together received 2.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (38 papers), Allergic Rhinitis and Sensitization (22 papers), Sinusitis and nasal conditions (16 papers), Eosinophilic Esophagitis (6 papers), IL-33, ST2, and ILC Pathways (6 papers), Eosinophilic Disorders and Syndromes (5 papers), Immune Cell Function and Interaction (5 papers) and Obesity, Physical Activity, Diet (4 papers). The work is most often cited by research in Immunology and Allergy (444 citations), Physiology (845 citations), Otorhinolaryngology (135 citations), Emergency Medical Services (190 citations) and Immunology (550 citations). Akira Kanda has collaborated with scholars based in Japan, France and United States. Frequent co-authors include David Dombrowicz, Sébastien Fleury, Valérie Julia, Nicolas Glaichenhaus, Julie Cazareth, Yoshiki Kobayashi, Valérie Verhasselt, Hiroshi Iwai, Mikiya Asako and Shigeharu Ueki. Their work appears in journals such as Allergology International, Mucosal Immunology, The Journal of Immunology, Journal of Cardiovascular Pharmacology and Biomolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026